Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia

Published:2024-07 Issue: Volume:593 Page:216970
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Dan^ORCID,He Jing,Liu Siyang,Zhang Haixia,Tang Daolin,Chen Pan,Yang Minghua^ORCID

Publisher

Elsevier BV

Reference51 articles.

1. Acute myeloid leukaemia;DiNardo;Lancet,2023

2. De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017;Sasaki;Cancer,2021

3. BCL2 and MCL1 inhibitors for hematologic malignancies;Roberts;Blood,2021

4. Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period;Juliusson;Blood,2019

5. Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia;Konopleva;Cancer Discov.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP